BAY-9683

• UNSPSC Description:

  BAY-9683 is an orally active covalent PPARG inverse agonist. BAY-9683 can be used in the study of diseases with overactive PPARG, such as luminal bladder cancer[1].

• Target Antigen:

  PPAR

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/bay-9683.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=CC(N2CCOCC2)=CN=C1NC(C3=C(Cl)C=C(F)C(C(NCC4=CC=C(F)C(F)=C4)=O)=C3)=O

• Molecular Weight:

  518.92

• References & Citations:

  [1]Orsi DL, et al. Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists. Bioorg Med Chem. 2023 Jan 15;78:117130.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2891706-83-3